626EGP
- Active ingredient
- empagliflozin
- Strength
- 25mg
- Form
- tablet
- Manufacturer
- boehringer ingelheim > united company for trading & distribution
- Route
- oral.solid
Uses
Used with diet and exercise to improve glycemic control in type 2 diabetes mellitus and to reduce cardiovascular and renal risks in appropriate patients.
Do not use if
Contraindicated in severe renal impairment, diabetic ketoacidosis, and hypersensitivity to empagliflozin.
Side effects
Genital fungal infections, urinary tract infections, dehydration, dizziness, and increased urination may occur.
Warnings
May cause ketoacidosis, volume depletion, and serious urinary or genital infections.
How it works
SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion.
Storage
Store at 20–25°C.
